To determine the influence of ECP therapy on the anti-viral/tumor capacity of NK cells, a specialized anti-viral/tumor population, CD56dimCD57+NKG2C+ NK cells (24), as well as the quality and quantity of NK activity were monitored during ECP treatment. Here, KLRC2 is linked to neoplasm.